Our Faculty
Robert Hudak, M.D.
Publications of Robert Hudak, M.D.
Quick Take Vol. 60
0.50 CMEs
In this Quick Take volume, our faculty discuss the effectiveness of adjunctive cariprazine in the treatment of major depressive disorder with inadequate response to antidepressants and low-dose risperidone for delirium in elderly orthopedic patients. Our experts also examine the efficacy of memantine for trichotillomania and skin-picking disorder and investigate the link between psychiatric disorders and increased risk for cardiovascular disease. Finally, the real-world effectiveness of pharmacologic treatments for bipolar disorder is discussed.
Obsessive-Compulsive and Related Disorders – Interview
0.50 CMEs
In this interview, Dr. Robert Hudak discusses the varying presentations of obsessive–compulsive and related disorders and challenges in their management. He emphasizes an integrated approach in the treatment of obsessive–compulsive and related disorders and discusses practical recommendations for the psychopharmacologic management of these disorders.
Treatment-Resistant Obsessive-Compulsive Disorder – Interview
0.75 CMEs
In this interview, Dr. Robert Hudak discusses management strategies for obsessive-compulsive disorder. He describes the complex presentations of obsessive-compulsive disorder and reviews the central roles of SSRIs and ERP as first-line treatment approaches for OCD. He further discusses dosing strategies, use of adjunct medications, treatment of patients with OCD and comorbid psychiatric conditions, and other somatic therapies for OCD.
Obsessive-Compulsive and Related Disorders
1.00 CMEs
In this presentation, Dr. Robert Hudak discusses obsessive-compulsive and related disorders, including hoarding disorder, BFRBs, and body dysmorphic disorder. He also guides clinicians on how to diagnose these disorders and the appropriate treatment for each one, such as SSRIs, augmentation strategies, and CBT.
Treatment-Resistant Obsessive-Compulsive Disorder
1.25 CMEs
In this presentation, Dr. Robert Hudak discusses treatment-resistant OCD, including definition and adequate treatment trials. He reviews aspects related to pharmacologic treatment, like augmentation and switching, as well as ECT, TMS, and surgical procedures for refractory cases.